Hemophilia A. SIPPET study selected by the American Society of Hematology
Presented at the ASH Congress in Orlando, it was chosen from amongst approximately three thousand studies
Kedrion among the key players of Farmindustria’s roadshow in Siena
The Lucca-based company presented as one of the innovative pharmaceutical companies in Tuscany
Revolutionary PID testing from Tuscany, Italy
Kedrion at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies
Kedrion Continues Global Expansion with Dedication Ceremony at US Facility
Biopharma Company Celebrates with Local Guests and Dignitaries in Melville, New York
Kedrion supported the XI World Hemophilia Day
An increasingly tailor-made prophylaxis lets sports and hemorrhagic conditions live together
Fighting diseases of the new-born: Kedrion attended UENPS conference
The company also supported a mini-marathon to eradicate HDFN
Kedrion Participates in International Event on Primary Immunodeficiencies
Biennial Meeting of the European Society for Immunodeficiencies (ESID) took place in late October in Prague
Festival della Salute: conference on self-sufficiency supported by Kedrion
Plasma and plasma-derived products take centre stage at a workshop with all the stakeholders of the Italian Blood System
Award in the US for efforts to support hemophilia patients communities
Kedrion’s Vice-President of North American Commercial Operations is “Man of the Year” for the Hemophilia Association of New Jersey
Conference in Colombia: Professor Mannucci on the future of hemophilia
The event, open to industry experts, patients’ associations and the scientific community, took place in Medellín on February 12th, 2014